protease-activated receptor-3 in podocytes Cytoprotective signaling by activated protein C requires
暂无分享,去创建一个
C. Esmon | J. Griffin | T. Madhusudhan | H. Gröne | Hongjie Wang | P. Nawroth | E. Gröne | B. Grinnell | B. Straub | V. Schwenger | J. Reiser | Qianxing Zhou | S. Müller-Krebs | B. Gerlitz
[1] T. Madhusudhan,et al. Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. , 2011, Blood.
[2] B. Molitoris,et al. Activated protein C and acute kidney injury: Selective targeting of PAR-1. , 2009, Current drug targets.
[3] Lee D. Hallagan,et al. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. , 2009, The Journal of clinical investigation.
[4] H. Anders,et al. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. , 2009, The American journal of pathology.
[5] D. Frommhold,et al. Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1–, Phospholipase-Cβ–, Phosphoinositide 3-Kinase–, and Nitric Oxide–Dependent Signaling in Monocytes and Promotes Plaque Stability , 2009, Circulation.
[6] J. Trejo,et al. Proteases display biased agonism at protease-activated receptors: location matters! , 2009, Molecular interventions.
[7] José A Fernández,et al. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity , 2009, The European journal of neuroscience.
[8] S. Shankland,et al. Inducible rodent models of acquired podocyte diseases. , 2009, American journal of physiology. Renal physiology.
[9] Hiroshi Deguchi,et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells , 2009, Proceedings of the National Academy of Sciences.
[10] Kwanghee Kim,et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A , 2008, Nature Medicine.
[11] J. Bae,et al. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells , 2008, Journal of thrombosis and haemostasis : JTH.
[12] G. Reiser,et al. The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release , 2008, Cellular and Molecular Life Sciences.
[13] P. Carmeliet,et al. Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.
[14] C. Derian,et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.
[15] J. Bae,et al. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. , 2007, Blood.
[16] L. O'Brien,et al. Activated Protein C Decreases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[17] C. Esmon,et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis , 2007, Nature Medicine.
[18] B. Molitoris,et al. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. , 2007, American journal of physiology. Renal physiology.
[19] J. Griffin,et al. The cytoprotective protein C pathway. , 2007, Blood.
[20] A. Malik,et al. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.
[21] G. Sandusky,et al. Role of protein C in renal dysfunction after polymicrobial sepsis. , 2007, Journal of the American Society of Nephrology : JASN.
[22] J. Bae,et al. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[23] J. Garcia,et al. Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.
[24] C. Feistritzer,et al. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.
[25] C. Esmon,et al. PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin* , 2005, Journal of Biological Chemistry.
[26] P. Henklein,et al. Proteinase-activated receptors (PARs)—the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1 , 2005, Regulatory Peptides.
[27] M. Hollenberg,et al. Tethered ligand‐derived peptides of proteinase‐activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells , 2004, Immunology.
[28] José A Fernández,et al. Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 , 2004, Neuron.
[29] M. Francolini,et al. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains , 2003, Oncogene.
[30] K. Schrör,et al. Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells , 2003, Thrombosis and Haemostasis.
[31] Joseph Parello,et al. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.
[32] B. Isermann,et al. The thrombomodulin–protein C system is essential for the maintenance of pregnancy , 2003, Nature Medicine.
[33] Matthias Kretzler,et al. Cell biology of the glomerular podocyte. , 2003, Physiological reviews.
[34] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[35] M. O'hare,et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.
[36] A. Kuliopulos,et al. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Bar-Shavit,et al. Signalling pathways induced by protease‐activated receptors and integrins in T cells , 2002, Immunology.
[38] P. L. Becker,et al. Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.
[39] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[40] S. Okumura,et al. Colocalization of β‐adrenergic receptors and caveolin within the plasma membrane , 1999 .